Microfluidics-imaging platform detects cancer growth signaling in minute biopsy samples

Researchers have developed an in vitro method to assess kinase activity in minute patient samples. The method involves an integrated microfluidics and imaging platform that can reproducibly measure kinase enzymatic activity from as few as 3,000 cells. The new method will enable faster and more efficient screening and analysis for improved diagnostics of rare cell populations.

Read the whole article on Science Daily

More from Science Daily